MEOX2 and lung carcinoma: In conclusion, here we have reported for the first time the functional and clinical correlations of the overexpressed MEOX2-GLI1 transcriptional axis, both as a novel molecular candidate axis involved in lung cancer drug resistance and as a predictor of therapy prognosis.